OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic s... OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 101315 | 1.0E-6 | CS |
| 4 | -3.0E-6 | -75 | 4.0E-6 | 4.0E-6 | 1.0E-6 | 29492 | 1.14E-6 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.27505 | 1.0E-6 | 71816 | 1.01E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 0.27505 | 1.0E-6 | 61493 | 1.01E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.27505 | 1.0E-6 | 125630 | 1.0E-6 | CS |
| 156 | 0 | 0 | 1.0E-6 | 0.27505 | 1.0E-6 | 96907 | 1.11E-6 | CS |
| 260 | -0.008699 | -99.9885057471 | 0.0087 | 0.27505 | 1.0E-6 | 337278 | 0.00319509 | CS |
realnewb
7月前
dilligence
1年前
Jbone22
1年前
Jbone22
1年前
SuperUnicorn66
2年前
SuperUnicorn66
2年前
swamp boy
2年前
DGlover
2年前
cleanliving
2年前
fat_tire
2年前
swamp boy
2年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。